Filing Flows › CareDx (CDNA) › Capital expenditures
CareDx (CDNA) capital expenditures by quarter
CareDx's capital expenditures were $1.6M in Q3 2026 (third quarter 2026), -13% from Q2 2026. Over the last 6 quarters it ranged from $1.0M (Q2 2025) to $3.8M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.6M | -13% | +24% |
| Q2 2026 | $1.9M | -51% | +85% |
| Q1 2026 | $3.8M | +94% | — |
| Q4 2025 | $2.0M | +51% | — |
| Q3 2025 | $1.3M | +30% | — |
| Q2 2025 | $1.0M | — | — |
Q3 2026 at a glance
CareDx, Q3 2026: revenue $139M (+39% year over year), operating margin 5.8%, net earnings $19.3M, operating cash flow $12.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is CareDx's capital expenditures?
CareDx's capital expenditures were $1.6M in Q3 2026 (third quarter 2026), -13% from Q2 2026.
How has CareDx's capital expenditures changed?
Over the last 6 quarters it ranged from $1.0M (Q2 2025) to $3.8M (Q1 2026).